Key result
Having 5 or more infections in the 3 years preceding clinical onset doubled the hazard for pediatric multiple sclerosis compared with 0-4 infections (HR 2.18; 95% CI 1.12-4.30; p=0.02).
Why the study?
Does a higher cumulative number of childhood infections increase the risk of pediatric multiple sclerosis?
Case-Control (n=1,272)
Does a higher cumulative number of childhood infections increase the risk of pediatric multiple sclerosis?
A higher cumulative number of childhood infections in the 3 years preceding onset is associated with an increased risk of pediatric multiple sclerosis.
Should not change clinical practice; hypothesis-generating for cumulative infections in pediatric MS etiology.
BACKGROUND: Infections are suspected environmental triggers for multiple sclerosis (MS). The relationship between the timing and cumulative number of childhood infections regarding pediatric MS risk is uninvestigated. OBJECTIVES: To investigate whether childhood infections contribute to pediatric MS. METHODS: A nationwide nested case-control study with detailed MS case ascertainment including chart review was undertaken. For each MS case, we selected five control children using density sampling from the entire Danish population, matching controls to children with MS by sex and birthdate. We analyzed data with the cumulative number of childhood infections as exposure and MS as outcome. Hazard ratios (HRs) including 95% confidence intervals (CIs) were estimated using Cox regression. RESULTS: We identified 212 children with MS and 1,060 controls. Median age at MS onset was 15.3 years (range: 7.6-17.8 years); 72% were girls. Each infection during the preceding 3 years increased the hazard for MS by 11% (95% CI = 1.01-1.22, p = 0.04); having 5+ infections compared with 0-4 infections in the preceding 3 years doubled the hazard for MS (HR: 2.18; 95% CI = 1.12-4.30, p = 0.02). CONCLUSION: Children with MS appeared to have more infections in the 3 years preceding MS clinical onset; accordingly, immune response to infections may influence MS pathogenesis.
No takes yet. Share an insight, caveat, or question.
Boesen et al. (2018) conducted a case-control in pediatric multiple sclerosis (n=1,272). Childhood infections (5 or more) vs. 0-4 infections was evaluated on Pediatric multiple sclerosis (HR 2.18, 95% CI 1.12-4.30, p=0.02). Having 5 or more infections in the 3 years preceding clinical onset doubled the hazard for pediatric multiple sclerosis compared with 0-4 infections (HR 2.18; 95% CI 1.12-4.30; p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: